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ReelinReelin is an extracellular glycoprotein that is highly conserved in mammals. In addition to its
expression in the nervous system, Reelin is present in erythroid cells but its function there is
unknown. We report in this study that Reelin is up-regulated during erythroid differentiation of
human erythroleukemic K562 cells and is expressed in the erythroid progenitors of murine bone
marrow. Reelin deﬁciency promotes erythroid differentiation of K562 cells and augments erythroid
production in murine bone marrow. In accordance with these ﬁndings, Reelin deﬁciency attenuates
AKT phosphorylation of the Ter119+CD71+ erythroid progenitors and alters the cell number and fre-
quency of the progenitors at different erythroid differentiation stages. A regulatory role of Reelin in
erythroid differentiation is thus deﬁned.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction receptor, and initiates cellular signals to regulate radial neuronalReelin is a large extracellular glycoprotein that is mainly
expressed in the nervous system. Reelin can also be detected in
several other organs and tissues, including the dental pulp, liver
and blood [1,2]. In the central nervous system Reelin binds to the
apolipoprotein E receptor 2 and very low density lipoproteinmorphology and cortical neuronal migration [3,4].
A number of studies indicate that Reelin is expressed in erythroid
cells and haematopoietic tissues. Reelin protein is present in human
erythroleukemia K562 and HEL cells [5]. Reelin transcript is induced
when K562 cells undergo erythroid differentiation concomitant
with mitochondria-dependent apoptosis [6]. In the developing
mouse, Reelin can be detected in the somites, yolk sac, and foregut
at E8.5 [7]. Reelin is one of the erythroid-enriched transcripts in
primitive erythroid precursors of E9.5 yolk sac [8], and is a target
gene of the transcription factor Kruppel-like factor 2, which is re-
quired for erythroid development [9]. Nevertheless, it is not clear
whether Reelin has any functional role in erythroid differentiation.
In this study, both K562 cells [10] and Reelin-deﬁcient reeler
mice [11] were used as models to address the role of Reelin in ery-
throid differentiation. Reelin was up-regulated during sodium
butyrate (NaB)-induced erythroid differentiation of K562 cells.
The cells with Reelin deﬁciency display augmentation of erythroid
differentiation. Consistent with these ﬁndings, reeler mice display
an increase in RBC count, hemoglobin (Hb) content, hematocrit
(Hct) and mean corpuscular hemoglobin concentration (MCHC)
in the peripheral blood, and augmented RBC production in bone
marrow. This study thus identiﬁes a negative regulatory role of
Reelin in erythroid differentiation.
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2.1. Materials
NaB was purchased from MERCK (Frankfurt, Germany).
3,30,5,50-tetramethylbenzidine (TMB) and brillant cresyl blue were
purchased from SIGMA (Saint Louis, MO). Anti-Reelin monoclonal
antibody 142 was purchased from Calbiochem (San Diego, CA).
The anti-mouse CD16/32, ﬂuorescein isothiocyanate (FITC)-conju-
gated anti-mouse Ter119 (FITC-Ter119), FITC-conjugated anti-
mouse IgG2b (FITC-IgG2b), and 7-aminoactinomycin D (7-AAD)
were purchased from eBioscience (San Diego, CA). The R-Phycoer-
ythrin (PE)-conjugated anti-mouse CD71 (PE-CD71) and PE-conju-
gated anti-mouse IgG1 (PE-IgG1) were purchased from
PharMingen (San Diego, CA). The anti-b-actin antibody was from
Novus Biologicals (Littleton, CO). The anti-phospho-AKT (S473)
antibody was purchased from Epitomics (Burlingame, CA). The
anti-AKT and anti-tubulin antibodies were from Cell Signaling
(Danvers, MA). Lentivirus-based expression plasmids encoding
short-hairpin interfering RNA for Reelin and luciferase were pro-
vided by the National RNAi Core Facility, Academia Sinica, Taiwan.
The Quantikine ELISA mouse erythropoietin immunoassay was
purchased from R&D Systems (Minneapolis, MN). The Iron liquicol-
or and the total iron binding capacity (TIBC) kits were purchased
from HUMAN Diagnostics (Wiesbaden, Germany).
2.2. Animals, genomic DNA isolation and genotyping
The B6C3Fe-a/a-Relnlrl strain of heterozygous reeler mice (here-
after named Reln+/) was obtained from Jackson Laboratory (Bar
Harbor, ME). Reln+/ mice were interbred to generate wild type
(hereafter named Reln+/+), heterozygous and homozygous (hereaf-
ter named Reln/) reelermice. The animal work has been reviewed
and approved by the Institutional Animal Care and Use Committee.
Two to three week-old mice were used in this study. Genomic DNA
isolation was performed as described in the Supplementary meth-
ods, and genotyping of new pups was performed as described pre-
viously [12] and in the Supplementary methods.
2.3. Cell culture, erythroid differentiation and benzidine staining
K562 cells were maintained in RPMI-1640 supplemented with
5% fetal bovine serum (FBS). Erythroid differentiation of K562 cells
was induced by treatment with NaB. The extent of erythroid differ-
entiationwas determined by benzidine staining using TMB solution
as described in the Supplementary methods [13]. The percentage of
TMB-positive cells was determined by counting a total of 200 cells
under a phase contrast microscope at 100X magniﬁcation.
2.4. Generation of shReln and shLuc stable cell lines, preparation of cell
lysates and Western blot analysis
Lentiviruses encoding short-hairpin interfering RNA were
produced to infect K562 cells and to establish shReln or shLuc stable
cell lines [14]. At 24 h post-infection, stable cloneswere selected for
3 weeks by addition of 1 lg/ml puromycin, and were maintained in
culture medium containing 0.7 lg/ml puromycin. Pooled clones
were used in this study to avoid the effects of different erythroid
differentiation efﬁciencies arising from simple subcloning [15].
Preparation of cell lysates and Western blot analysis was per-
formed as described previously [16]. The concentrations for the
primary antibodies used in this study were anti-Reelin (1:1000),
anti-phospho-AKT (S473) (1:1000), anti-AKT (1:1000), anti-b-actin
(1:10000) and anti-tubulin (1:5000). The band intensity was quan-
tiﬁed by ImageJ software (National Institute of Health).2.5. Real-time reverse transcription PCR
Real-time RT-PCR was performed as described in the Supple-
mentary methods. Relative gene expression with b-actin or
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as the
normalization control was determined by the 2DDCt method where
Ct = threshold cycle [17]. The primer sets for PCR ampliﬁcation
were Reln-forward primer (50-TGCACGACCGGTGCCATCTG-30) and
Reln-reverse primer (50-TTGGCTGGTGCTGGGCGATG-30); b-actin-
forward primer (50-TCACCCACACTGTGCCCATCTACG-30) and b-actin-
reverseprimer (50-CAGCGGAACCGCTCATTGCCAATG-30);mouseReln
forward primer (50-CAAGAACAATACCGCTGATTGG-30) and mouse
Reln reverse primer (50-GATGTGGATGACTGTGCTCACA-30); mouse
GAPDH forward primer (50-AGCCTCGTCCCGTAGACAAA-30) and
mouse GAPDH reverse primer (50-CCTTGACTGTGCCGTTGAAT-30).
2.6. Bone marrow sections and hematoxylin and eosin (HE) staining
Mouse femurs were ﬁxed in 4% paraformaldehyde in 0.1 M
phosphate buffer, pH 7.4, at 4 C overnight. The tissues were decal-
ciﬁed with 15% EDTA and were embedded in parafﬁn. The parafﬁn
sections (5 lm) were deparafﬁnised and stained with Mayer’s
hematoxylin and eosin solution.
2.7. Determination of RBC-related haematological proﬁles
Mouse whole blood was collected by retro-orbital puncture into
a 0.5 ml EDTA.K3 vacuum blood collection tube. The RBC count,
mean corpuscular volume (MCV), mean corpuscular hemoglobin
(MCH), MCHC and red blood cell distribution width (RDW) were
determined using the SYSMEX XT-1800i analyzer (Kobe, Japan).
2.8. Determination of reticulocyte production index (RPI)
The peripheral bloodwasmixedwith an equal volume of 1% bril-
liant cresyl blue solution for reticulocyte staining. The number of
reticulocytes that was revealed during the process of counting
1000 RBC was used to deﬁne the percentage of reticulocyte in the
RBC population (% reticulocyte). The reticulocyte production index
(RPI) was calculated according to the equation RPI = % reticulo-
cyte  (Hct of the test sample/meanHct ofwild type), assuming that
the maturation rate for the wild type and Reln/ reticulocytes is
equal.
2.9. Determination of plasma EPO, plasma iron, and total iron binding
capacity (TIBC)
Heparinized plasma from peripheral blood collected by cardiac
puncture was obtained by centrifugation at 1200g for 10 min.
Plasma EPO levels were determined using the Quantikine ELISA
mouse erythropoietin immunoassay as described by the manufac-
turer (R&D Systems). Plasma iron levels were determined using the
Iron liquicolor kit (HUMAN Diagnostics). For measurement of TIBC,
heparinized plasma (20 ll) was added to 40 ll excess Fe(III) iron
buffer and then aluminum oxide was used to absorb and precipi-
tate unbound iron. After centrifugation, the supernatant was col-
lected for TIBC detection (5 ll) as described by the manufacturer
(HUMAN Diagnostics).
2.10. Flow cytometry analysis of cell population in the erythroid
lineage
The assay is based on the expression of cell-surface erythro-
blast-speciﬁc epitope Ter119 together with CD71 (the transferrin
receptor) and the forward scatter (FSC) parameter [18]. Bone
marrow cells were obtained from mouse femurs and washed with
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32, the cells were incubated on ice for 1 h with FITC-Ter119
(0.25 lg) and PE-CD71 (0.2 lg) antibodies in 5% FBS–PBS. Control
samples were incubated with the FITC-IgG2b and PE-IgG1 isotype
control antibody. 7-AAD was used to exclude dead cells. Flow
cytometry was performed using the Accuri 6 Cell Analyzer (BD Bio-
sciences, San Diego, CA) and the distribution of cell populations
was analyzed by FlowJo software (Tree star Inc., Ashland, OR). All
Ter119-positive cells were classiﬁed into four subsets: ProE
(Ter119medCD71high), EryA (Ter119highCD71highFSChigh), EryB
(Ter119highCD71highFSClow) and EryC (Ter119highCD71lowFSClow),
corresponding to the morphologically recognized proerythroblasts
and basophilic, polychromatic and orthochromatic erythroblasts,
respectively. Mouse progenitor cells for detection of Reln mRNA
and AKT-S473 phosphorylation were sorted by FACSAria cell sorter
based on the expression of Ter119 and CD71.
2.11. Statistical analysis
Student’s t-test or One-way ANOVA followed by Bonferroni’s
multiple comparison test was used for statistical analysis. A
P < 0.05 was considered as statistically signiﬁcant.
3. Results
3.1. Reelin expression is up-regulated during NaB-induced erythroid
differentiation of K562 cells
Because they express Reelin [5] and are able to differentiate into
lineage-speciﬁcbloodcells [19], K562cellswereused in this study to
address the role of Reelin in erythroid differentiation. Western blot
analysis revealed that the full-length 420 kDa Reelin protein was
elevated by NaB in a dose-dependent manner (Fig. 1A). In addition,
the 180 kDa immunoreactive band corresponding to the proteolytic
productofReelin [2]wasalsodetectable. Timecourse study revealed
that NaB-induced up-regulation of Reelin was sustained for more
than 48 h (Fig. 1B) with 11.3 ± 2.0 (n = 3) and 12.4 ± 2.8 (n = 3) fold
increase at 24 and 48 h after NaB treatment, respectively
(P < 0.05). The slight increase in Reelin without sodium butyrate is
likely a consequence of spontaneous erythroid differentiation [20].
These results indicate that Reelin is up-regulated during erythroid
differentiation of K562 cells.
To determine whether ReelinmRNA is up-regulated during NaB-
induced erythroid differentiation, real-time RT-PCR was performed
to quantify Reelin mRNA expression. When compared to theFig. 1. Reelin expression is up-regulated during NaB-induced erythroid differentiation o
NaB for 24 h (panel A) or were cultured in the presence or absence of NaB (0.5 mM) for 2
the expression of b-actin as the control for equal protein loading. The band intensity of R
the mean ± S.E.M. of 3 independent experiments with Reelin expression in the untreated
with NaB or solvent control for 24 h. Relative Reelin mRNA expression in the control a
mean ± S.E.M. of 3 independent experiments with Reelin mRNA expression in the untreauntreated control cells, Reelin mRNA was increased by
2.43 ± 0.14-fold (Fig. 1C, P < 0.01, n = 3) and thus may contribute
to the increase in Reelin protein.
3.2. Deﬁciency of Reelin enhances erythroid differentiation of K562
cells
To elucidate the roles of Reelin in NaB-induced erythorid differ-
entiation, K562 stable cell lines were established expressing Reelin
(shReln) and luciferase (shLuc) short-hairpin interfering RNA. Be-
cause the presence of Reelin in FBS (Supplementary Fig. 1) can
potentially mask the effect of Reelin knockdown, erythroid differ-
entiation was performed in serum free (and thus ‘‘Reelin-free’’)
OPTI-MEM to eliminate this possible interference. Under these
conditions, both basal and NaB-induced Reelin expression was
diminished in the shReln cells (Fig. 2A). At 48 h after differentiation
induction, shReln cells had a 38% increase in TMB-positive cells
when compared to shLuc cells (Fig. 2B, 26.5% for shReln vs. 19.2%
for shLuc; P < 0.05, n = 10). Reelin deﬁciency thereby enhances
erythroid differentiation of K562 cells.
3.3. Erythrocyte production is increased in homozygous reeler mice
To conﬁrm the effect of Reelin knockdown on augmenting
erythroid differentiation of K562 cells, and to determine whether
Reelin deﬁciency enhances erythroid differentiation and RBC
production in vivo, RBC-related indexes for Reln+/+, Reln+/ and
Reln/ mice were assessed. Reln+/+ and Reln+/ mice displayed
similar RBC-related indexes (Table 1). In contrast, when compared
to the Reln+/+ mice, the RBC count, Hb content, Hct and MCHC for
Reln/ mice was increased by 31.3%, 25.4%, 17.2% and 7.2%,
respectively (Table 1, P < 0.001). Moreover, Reln/ mice had an
11.4% decrease in MCV (P < 0.001). No difference for MCH and
RDW was observed between Reln+/+ and Reln/ mice.
The increase in RBC count and Hb content led us to investigate
whether the polycythemia in Reln/ mice is a primary conse-
quence of Reelin deﬁciency on erythroid differentiation or a
secondary event driven by factors outside the erythroid compart-
ment. The JAK2-V617F mutation, known to be associated with
the acquired type of primary polycythemia [21], is not present in
Reln/ mice (not shown) and in any event is on chromosome 19
and thus would not co-segregate with the reelin gene on chromo-
some 5. Analyses of plasma iron content (210.5 ± 34.2 mg/dl for
Reln+/+ (n = 4) vs. 180.4 ± 41.8 mg/dl for Reln/ (n = 5), p = n.s.)
and TIBC levels (350.9 ± 46.0 mg/dl for Reln+/+ (n = 4) vs.f K562 cells. (A and B) K562 cells were treated with the indicated concentrations of
4 h and 48 h (panel B). Reelin expression was determined by Western blotting, with
eelin normalized by b-actin was quantiﬁed by ImageJ software. The data represent
control cells at 0 h arbitrarily set as 1 (panel B). ⁄P < 0.05. (C) K562 cells were treated
nd NaB-treated cells was determined by real-time RT-PCR. The data represent the
ted control cell arbitrarily set as 1. C, control cells; N, NaB-treated cells. ⁄⁄P < 0.01.
Fig. 2. Knockdown of Reelin expression enhances erythroid differentiation of K562 cells. (A and B) NaB-induced erythroid differentiation was performed in OPTI-MEM for 24
(panel B) or 48 h (panel A and B). Reelin expression was determined by Western blotting, with the expression of b-actin as the control for equal protein loading (panel A,
upper panel). Data represent the mean ± S.E.M. (n = 5) for the relative levels of Reelin expression (panel A, lower panel). Reelin expression in the NaB-treated shLuc cells was
arbitrarily set as 1. The extent of erythroid differentiation was determined by TMB staining (panel B, upper panel). A total of 200 cells were counted and the percentage of
TMB-positive cells is shown (panel B, lower panel). The data represent the mean ± S.E.M. of 10 independent experiments. ⁄⁄P < 0.01; ⁄⁄⁄P < 0.001. Representative phase
contrast microscopy images of TMB-stained cells are shown (panel B, upper panel). C, control untreated cells; N, NaB-treated cells.
Table 1
RBC proﬁles of Reln+/+, Reln+/ and Reln/ mice.
Parametersa Reln+/+ (n = 8) Reln+/ (n = 10) Reln/ (n = 6)
RBC (M/ll) 8.0 ± 0.2 8.1 ± 0.1 10.5 ± 0.2***
Hb (g/dl) 12.2 ± 0.3 12.2 ± 0.2 15.3 ± 0.2***
HCT (%) 46.0 ± 1.1 46.6 ± 0.8 53.9 ± 0.8***
MCV (ﬂ) 57.7 ± 0.4 57.6 ± 0.5 51.1 ± 0.4***
MCH (pg) 15.3 ± 0.2 15.1 ± 0.2 14.6 ± 0.2
MCHC (g/dl) 26.5 ± 0.3 26.2 ± 0.2 28.4 ± 0.4***
RDW (%) 20.0 ± 0.6 18.9 ± 1.5 22.8 ± 0.3
a One-way ANOVA followed by Bonferroni’s multiple comparison test was used
for statistical analyses. Data are expressed as mean ± S.E.M.
*** P < 0.001 when compared to Reln+/+ mice.
H.-C. Chu et al. / FEBS Letters 588 (2014) 58–64 61357.5 ± 34.8 mg/dl for Reln/ (n = 5), p = n.s.) revealed that these
two parameters were comparable between Reln+/+ and Reln/
mice (Fig. 3A). However, Reln/ mice exhibited a signiﬁcant
decrease in RPI (16.4 ± 1.30 for Reln+/+ (n = 3) vs. 9.0 ± 1.1 for
Reln/ (n = 3), P < 0.01) and plasma EPO levels (182.1 ± 7.0 pg/ml
for Reln+/+ (n = 7) vs. 57.8 ± 5.9 pg/ml for Reln/ (n = 7), P < 0.001)
when compared to the Reln+/+ mice (Fig. 3A). Hence, iron loss and
augmentation of EPO production are not the driving factors leading
to erythrocytosis in Reln/ mice.
In contrast to the normal organ size of heart and kidney, Reln/
mice had a relatively small spleen size (0.58 ± 0.04% of body weight
for Reln+/+ (n = 3) vs. 0.20 ± 0.01% for Reln/ (n = 3), P < 0.001)
(Fig. 3B). Erythrocytosis in Reln/ mice is thus not likely a conse-
quence of extramedullary erythropoiesis in spleen, which is usu-
ally associated with splenomegaly.
3.4. Reelin deﬁciency attenuates phosphorylation of the Reelin
signaling protein AKT and alters the number and frequency of
erythroid progenitors in bone marrow
We determined whether the augmentation of erythroid
production in Reln/ mice is related to the bone marrow
erythropoiesis activity. The femurs from Reln+/+ and Reln/ mice
were acquired for bone marrow section analysis and for pheno-
typic characterization. The gross view showed that femurs fromReln/ mice were slightly shorter (20%) than the femurs from
Reln+/+ mice and appeared dark red (Fig. 4A). After normalization
by the bone length, the number of erythrocytes, as deﬁned by
the shape of biconcave discs with no nuclei, was increased in the
Reln/ mice bone marrow sections (13.0 ± 1.9 RBC/section for
Reln+/+ (n = 5) vs. 175.8 ± 30.8 RBC/section for Reln/ (n = 5,
P < 0.001, Fig. 4A).
We therefore performed ﬂow cytometric assays that allow di-
rect identiﬁcation and analysis of proerythroblasts and erythro-
blasts in freshly isolated hematopoietic tissue. The histograms
illustrating the distribution of erythroid lineage bone marrow cells
indicated that Reln+/+ and Reln/ mice displayed different erythro-
poietic activity (Fig. 4B). Reelin transcript was expressed in the
Ter119+CD71+ progenitors from the Reln+/+ mice (Fig. 4C). In the
absence of Reelin expression, the phosphorylation and hence the
activation of the Reelin signaling protein AKT [22] was attenuated
by 50% (P < 0.05, Fig. 4D). Attenuation of AKT phosphorylation
associated with Reelin deﬁciency was further conﬁrmed in the
shReln-K562 cells that underwent erythroid differentiation (Sup-
plementary Fig. 2). According to the histogram for the distribution
of erythroid progenitors (Fig. 4B), Reln/ mice displayed a signiﬁ-
cant increase in the number of middle and late (EryB + EryC) stages
of erythroid progenitors in the bone marrow (Fig. 4E, left panel).
When different subsets of erythroid progenitors were analyzed,
the Reln/ mice displayed a decrease in the frequency for the pro-
erythroblasts (ProE) and the early stage (EryA) erythroblasts
(P < 0.001), with a signiﬁcant increase in the frequency of the mid-
dle (EryB) and late (EryC) stages of erythroblast, (P < 0.001) when
compared to the Reln+/+ mice (Fig. 4E, right panel). These data
imply that Reelin deﬁciency attenuates AKT phosphorylation and
enhances RBC production in bone marrow.
4. Discussion
In the present study, we found that Reelin is up-regulated
during NaB-induced erythroid differentiation of K562 cells. Rather
than promoting erythorid differentiation, Reelin negatively
regulates this process in erythroleukemia cells. Accordingly,
Fig. 3. Reeler mice display an increase in RBC production independent of factors outside the erythroid compartment. (A) The plasma from Reln+/+ and Reln/ mice was
collected for reticulocyte count and the analyses of EPO and iron content. Data represent the mean ± S.E.M. of 3–7 independent experiments. n.s., not signiﬁcant. (B) The
image (left panel) and the weight (right panel) for the indicated organs collected from the Reln+/+ and Reln/mice are shown. Data represent the mean ± S.E.M. (n = 3) for the
weight of organs after normalization by the body weight.
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bone marrow, with an increase in RBC count and an alteration of
RBC-related indices in peripheral blood. This study thereby
deﬁnes for the ﬁrst time a negative regulatory role of Reelin in
erythroid differentiation.
Erythropoiesis is augmented by several factors including EPO,
KIT ligand, oncostatin-M, and glucocorticoids [23]. However, less
is understood concerning factors that limit this process. Putative
negative regulators such as DYRK3 and DAPK2 have been proposed
to act coordinately to control erythroid production [24]. Both
DYRK3 and DAPK2 are expressed selectively in late erythroid
progenitor cells in mice, and are proven to attenuate erythroblast
formation and RBC production [25,26]. Experimental evidence
obtained in this study demonstrates that Reelin may play a mean-
ingful role as an erythropoietic suppressor to limit the process of
erythropoiesis. The inhibitory effect of Reelin on erythroid differ-
entiation was apparent when K562 cells were induced to differen-
tiate in OPTI-MEM culture medium, but not in RPMI-1640
supplemented with 5% FBS. Whether the presence of growth
factors or the like in FBS masks the effect of Reelin is worthy of fur-
ther investigation. Despite this, the data suggest that Reelin be
added to the list of regulators that negatively control erythroid
differentiation.
Although the upregulation of Reelin in erythroid differentiated
K562 cells appears to contradict the role of Reelin as a negative
regulator of erythroid differentiation, we can not rule out that dif-
ferentiation signals induced by sodium butyrate may at the same
time initiate a cellular process to control the extent of erythroid
differentiation and hence the homeostasis of K562 cells. It is also
likely that Reelin signaling and regulation is relatively sophisti-
cated in vivo and can not be completely reﬂected in the K562 cell
model. Similar to this scenario, the roles of ERK1/2 activation in
erythroid differentiation are controversial in different in vitro
and in vivo models. For example, ERK1/2 activation is indispensible
for hemin- but not butyrate-induced erythroid differentiation of
K562 cells [27–29]. The MAPK/ERK pathway was also found to be
required in early but not in late erythroid progenitors in the self-
renewal of avian erythroid progenitors [30]. On the other hand,
activation of ERK1/2 by EPO and stem cell factor is important forexpansion of human primary erythroid progenitors but is not re-
quired for the renewal of primary murine erythroid progenitors
[31,32]. Moreover, ERK1/ mice display an enhanced splenic
erythropoiesis without any effect on bone marrow erythropoiesis,
implying that ERK1 is a negative regulator of the adult steady-state
splenic erythropoiesis [33]. These studies all point out the compli-
cated nature of the mechanisms regulating erythroid differentia-
tion, and thus validation of Reelin function in different erythroid
differentiation models is noteworthy.
Consistent with the previous report [22] showing that the
AKT pathway is one of the effectors in Reelin signaling, the
Ter119+CD71+ progenitors from Reelin-deﬁcient mice display a
decrease in AKT-Ser473 phosphorylation. Activation of AKT
through Ser473 phosphorylation is crucial for EPO-induced eryth-
ropoiesis and has fundamental roles in the regulation of cell cycle,
survival and differentiation [34,35]. However, as demonstrated by
the study of Breig et al., inhibition of PI3K/AKT signaling by
LY294002 downregulates Spi-1/PU.1 expression and is sufﬁcient
to induce hemoglobin synthesis and commit Friend erythroleuke-
mia cells to late erythroid differentiation [36]. Hence, AKT appears
to have dual role and, depending on the stage of erythroid
maturation, functions either as positive or negative regulator of
erythropoiesis. Based on the observations that Reelin-deﬁcient
Ter119+CD71+ progenitors display a decrease in AKT-Ser473
phosphorylation and the enhanced erythropoietic activity in reeler
mice, this study fuels the concept that, by regulating AKT
phosphorylation and activation, Reelin plays a pivotal role in the
ﬁnal maturation of steady state erythrocytes.
An increase in RBC count, Hb content, Hct, and MCHC in the
homozygous reeler mice provides a further link between Reelin
deﬁciency and polycythemia in vivo. The JAK2-V617F mutation is
the common cause of human polycythemia vera, an acquired type
of primary polythemia [21]. The reelermice do not inherit this type
of mutation, ruling out JAK2-V617F as the molecular basis for the
polycythemia associated with Reelin deﬁciency. Because of the de-
crease in plasma EPO and the normal plasma iron and TIBC levels,
the polycythemia in reelermice is not likely driven by these factors
outside the erythroid compartment. Moreover, the polycythemia
does not appear as a secondary event associated with neuronal
Fig. 4. Alteration of erythropoiesis activity in the bone marrow of Reln/mice. (A) The femurs of Reln+/+ and Reln/mice were collected at 3 weeks after birth for phenotypic
characterization (left panel) and for HE staining of bone marrow sections (middle panel). Erythrocytes indicated by white arrows were counted and the number of RBC per
bone marrow section was determined. Data (right panel) represent the mean ± S.E.M. (n = 5) for the number of RBC/section from the Reln+/+ and Reln/ mice. (B–E) Flow-
cytometric analysis of bone marrow cells labeled with antibodies directed against Ter119 and CD71. Ter119high cells were further analyzed with respect to FSC and CD71. The
histograms illustrate the distribution of erythroid lineage bone marrow cells from Reln+/+ and Reln/ mice (panel B). The Ter119+CD71+ progenitors from Reln+/+ or Reln/
mice obtained by FACSAria sorting were analyzed for Reelin mRNA expression (panel C) and AKT phosphorylation (panel D). For AKT phosphorylation, the data represent the
mean ± S.E.M. of 3 independent experiments with the phosphoryation level of AKT in Reln+/+ mice arbitrarily set to 100%. The mean ± S.E.M. for the number (n = 5, left panel)
and frequency (n = 6, right panel) of the indicated erythroid progenitors are also shown (panel E). NTC, no template control. ⁄P < 0.05; ⁄⁄P < 0.01; ⁄⁄⁄P < 0.001.
H.-C. Chu et al. / FEBS Letters 588 (2014) 58–64 63defects in reeler mice. Previous study showed that MCV is in-
creased or remains normal when secondary erythrocytosis occurs
in response to various diseases and symptoms [37]. In contradic-
tion to this scenario, reeler mice display a decrease in MCV. The
changes in the frequency and distribution of proerythroblasts
and erythroblasts in the bone marrow of reeler mice support the
notion that Reelin deﬁciency affects RBC differentiation. In addi-
tion, Reelin deﬁciency augments NaB-induced erythroid differenti-
ation of K562 cells, implying that Reelin indeed is involved in the
regulation of erythroid differentiation. Based on the in vitro and
in vivo studies, Reelin is likely to have a direct impact on erythroid
differentiation. Whether polycythemia plays a role in the neurode-
generative symptom in reeler mice is unknown. Excessive erythro-
cytosis by overexpressing Epo in a transgenic mouse model leads to
hepatic, renal, neuronal and muscular degeneration [38], implying
that either the increase in RBC number or the excessive EPO (which
does not occur in the reeler mice) could partially contribute to the
neuronal defects of reeler mice.Unveiling new molecules that regulate the survival and
maturation of erythrocytes is clinically important and relevant
to the anemia of chemotherapy, chronic myelodysplasia and
multiple myeloma. The ﬁndings we report herein provide a
new insight into the role of Reelin in erythroid differentiation,
and contribute to our understanding of the function of extra-
neuronal reelin.
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